NEW DELHI—India and China unwittingly turned rivals on the development of COVID-19 vaccines after competing Brazilian politicians ended up inviting China’s Sinovac and India’s Serum Institute amid delays in the production of Brazil’s own vaccine. Meanwhile, the country’s private clinics have turned to another Indian vaccine producer, Bharat Biotech, for 5 million doses of its…

NEW DELHI—Competing Brazilian politicians have ended up inviting both China’s Sinovac and India’s Serum Institute for COVID-19 vaccines amid delays in the production of Brazil’s own vaccine. Meanwhile, the country’s private clinics have turned to another Indian vaccine producer, Bharat Biotech, for 5 million doses of its COVID-19 vaccine called Covaxin. Brazil has the third-highest…